Long-range function of secreted small nucleolar RNAs that direct 2\u27-O-methylation by Rimer, Jamie M. et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2018 
Long-range function of secreted small nucleolar RNAs that direct 
2'-O-methylation 
Jamie M. Rimer 
Jiyeon Lee 
Christopher L. Holley 
Robert J. Crowder 
Delphine L. Chen 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Jamie M. Rimer, Jiyeon Lee, Christopher L. Holley, Robert J. Crowder, Delphine L. Chen, Phyllis I. Hanson, 
Daniel S. Ory, and Jean E. Schaffer 
Long-range function of secreted small nucleolar RNAs that
direct 2-O-methylation
Received for publication,April 11, 2018, and in revised form, June 18, 2018 Published, Papers in Press, July 6, 2018, DOI 10.1074/jbc.RA118.003410
Jamie M. Rimer‡, Jiyeon Lee‡, Christopher L. Holley‡, Robert J. Crowder‡, Delphine L. Chen‡§, Phyllis I. Hanson¶,
Daniel S. Ory‡, and X Jean E. Schaffer‡1
From the ‡Department of Medicine, §Mallinckrodt Institute of Radiology, and ¶Department of Cell Biology and Physiology,
Washington University School of Medicine, St. Louis, Missouri 63110
Edited by Karin Musier-Forsyth
Small nucleolar RNAs (snoRNAs) are noncoding RNAs that
guide chemical modifications of structural RNAs. Whereas
snoRNAs primarily localize in the nucleolus, where their canon-
ical function is to target nascent ribosomalRNAs for 2-O-meth-
ylation, recent studies provide evidence that snoRNAs traffic
out of the nucleus. Furthermore, RNA-Seq data indicate that
extracellular vesicles released from cells contain snoRNAs.
However, it is not known whether snoRNA secretion is
regulated or whether secreted snoRNAs are functional. Here,
we show that inflammation stimulates secretion of Rpl13a
snoRNAs U32a (SNORD32a), U33 (SNORD33), U34
(SNORD34), and U35a (SNORD35a) from cultured macro-
phages, in mice, and in human subjects. Secreted snoRNAs
co-fractionate with extracellular vesicles and are taken up by
recipient cells. In a murine parabiosis model, we demonstrate
that snoRNAs travel through the circulation to function in
distant tissues. These findings support a previously unappre-
ciated link between inflammation and snoRNA secretion in
mice and humans and uncover a potential role for secreted
snoRNAs in cell–cell communication.
The nearly 400 snoRNAs2 encoded within mammalian
genomes function in 2-O-methylation, pseudouridylation, or
processing of other cellular RNAs (1, 2). Typically, snoRNAs
direct these modifications on rRNAs and small nuclear RNAs,
with specificity in targeting achieved by base pairing between
the snoRNA antisense elements and their targets. Most mam-
malian snoRNAs are encoded within introns of host genes and
are released from intron lariats during splicing by debranching
and exonucleolytic cleavage (3). A small number of snoRNAs
are independently transcribed by RNA polymerase II, with an
m7G cap structure that becomes hypermethylated and a short
3 extension that is cleaved (4). The vast majority of cellular
snoRNAs localize with their substrates in the nucleus. Intronic
snoRNAs are produced within the nucleoplasm, complexed
with proteins, and transported to the nucleoli, where they are
well positioned to encounter nascent rRNA substrates (5). By
contrast, independently transcribed snoRNAs traffic to the
cytoplasm during their biogenesis and are efficiently retrieved
to the nucleus (6, 7).
A number of studies suggest that snoRNA localization to the
nucleus is dynamic and regulated. In the setting of serum star-
vation of fibroblasts, biogenesis of snoRNA U3 increases, and
abundance of U3 in the cytoplasm increases (8). Our own work
has demonstrated that the snoRNAs encoded in the Rpl13a
locus, U32a (SNORD32a), U33 (SNORD33), U34 (SNORD34),
andU35a (SNORD35a), are essential for the cell death response
to metabolic stress and accumulate in the cytosol of fibroblasts
and myoblasts in response to lipotoxic and oxidative stress (9).
RNA-Seq studies from our laboratory provided evidence that
box C/D snoRNAs as a class rapidly relocalize to the cytoplasm
following treatment of cardiomyoblasts with doxorubicin, a
known inducer of oxidative stress (10). This redistribution of
snoRNAs depends on superoxide and NADPH oxidase activity
and does not simply result from compromise of the nuclear
compartment. We also recently found that nuclear export fac-
tor 3 (NXF3) regulates the trafficking of snoRNAs between the
nucleus and cytosol (11). Importantly, regulated appearance of
snoRNAs in the cytoplasm raises the possibility of novel func-
tions for snoRNAs outside the nucleus.
Microarray and deep sequencing approaches have led to the
discovery of small noncoding RNAs in the extracellular space.
The most well studied of these species are miRNAs, which are
found in plasma in small membrane-bound vesicles or exo-
somes and/or bound to lipoproteins (12, 13). The abundance of
different miRNAs in plasma, serum, and urine tracks with a
spectrumof neurological, cardiovascular, oncologic,metabolic,
and hematological disorders, suggesting that miRNAs in the
blood can serve as biomarkers for disease processes (14). The
observations that miRNAs are transferred from donor to recip-
ient cells in which they impact gene expression and biological
functions indicate thatmiRNAs can play roles in cell–cell com-
munication (13, 15, 16).
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RNA-Seq has also revealed the presence of snoRNAs in the
medium of cultured cells (17–19) and in human plasma exo-
somes (20, 21). However, it is unclear whether secretion of this
class of noncoding RNAs is regulated, and in contrast to
miRNAs, their potential to function in non-cell-autonomous
roles is unknown. The present study was undertaken to further
characterize the extracellular trafficking of the four intronic
box C/D snoRNAs produced from the Rpl13a locus.
Results
Rpl13a snoRNAs accumulate in the culturemedium of
lipopolysaccharide (LPS)-stimulatedmacrophages
TheRpl13a snoRNAsU32a, U33, U34, andU35a accumulate
outside the nucleus of fibroblasts and cardiomyoblasts in the
setting of oxidative stress (9, 10, 22). To extend these findings to
another cell type in which oxidative stress plays a central role in
pathophysiologically important responses, we treated bone
marrow–derived macrophages with LPS, a stimulus known to
induce reactive oxygen species and inflammatory gene expres-
sion (23). Following exposure of macrophages to LPS, intracel-
lular reactive oxygen species are increased, as evidenced by
enhanced 2,7-dichlorodihydrofluorescein diacetate (DCF)
staining (Fig. 1A) and expression of the well-characterized
inflammatory response genes, cyclooxygenase 2 and tumor
necrosis factor- (COX2 and TNF; Fig. 1B). Stimulation with
LPS did not cause loss of cellular integrity, as assessed by LDH
release (Fig. 1C), or apoptosis, as assessed by caspase 3/7 activ-
ity (Fig. 1D). Using snoRNA-specific stem loop primers for
reverse transcription with qPCR amplification for detection,
we found that the Rpl13a snoRNAs rapidly increased in the
Figure 1. Macrophages secrete Rpl13a snoRNAs in response to lipopolysaccharide. Murine macrophages were treated with 50 ng/ml LPS. A, ROS
quantified after 8 h by DCF staining. B, qRT-PCR quantification of COX2 and TNF gene expression relative (rel) to Rplp0 at the indicated times. C, LDH release
following treatment with 50 ng/ml LPS for the indicated time. LDH-positive control and freeze-thaw lysis (MAX) are shown as controls.D, apoptosis quantified
by a caspase 3/7 activity assay. Cells were treatedwith 1.5M staurosporine (STS) for 4 h as a positive control. E, qRT-PCR of U32a, U33, U34, andU35a snoRNAs
in medium relative to C. elegansmiR39 spike-in. F and G, qRT-PCR quantification of Rpl13a snoRNAs U32a, U33, U34, and U35a relative to Rplp0 in cytosolic (F)
and nuclear (G) fractions. Results are mean S.E. (error bars) for n 3 per condition. p 0.05, using Student’s t test (#) or ANOVA with Dunnett’s multiple-
comparison test (*).
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medium following 1 h of stimulation and were cleared over the
subsequent 3 h (Fig. 1E). Increases in snoRNAs in the medium
were not accompanied by increase in cytosolic or nuclear
snoRNAabundance (Fig. 1,F andG). Absolute quantification of
snoRNAs using standard curves for each species demonstrated
that LPS-induced increases in snoRNAs in the medium are sig-
nificant and specific, but small relative to nuclear and total cel-
lular snoRNAabundance, pools that donot significantly change
with treatment (Fig. 2, A–D). Control PCRs indicated that the
target-specific stem-loop primed reverse transcription qPCR
method detects mature snoRNAs, but not snoRNA sequences
in DNA or pre-mRNA templates (Fig. 2E). These findings indi-
cate that LPS induces macrophage snoRNA secretion. Rapid
clearance of the snoRNAs from the medium suggests they may
be degraded, and decreases in cytosolic snoRNAs at 4 h (signif-
icant for U33 and U34 only) may reflect the cumulative export
over several hours. In addition to the Rpl13a snoRNAs, LPS
also stimulates the secretion of SNORD82, SNORD92, and
SNORA73b (Fig. 3), suggesting that LPS broadly stimulates
secretion of box C/D and box H/ACA snoRNAs.
Rpl13a snoRNAs are releasedwith extracellular vesicles
A growing body of literature provides evidence that RNAs
are released from cells in membrane-bound structures, gener-
ally referred to as extracellular vesicles (EVs) (24). Release of
Rpl13a snoRNAs from LPS-stimulatedmacrophages was unaf-
Figure 2. Detection of Rpl13a snoRNAs in medium is sensitive and specific. A–D, absolute abundance of Rpl13a snoRNAs. Standard curves display
amplification of each purified Rpl13a snoRNA (left) and corresponding absolute quantification of each snoRNA in medium, cytosol, nucleus, and whole cell
before and following treatment for 1hwith50ng/ml LPS (right) forU32a (A), U33 (B), U34 (C), andU35a (D). E, snoRNA-specific stem-loop (SL) primers for reverse
transcription fromRNAandDNA, comparedwitholigo(dT) priming (dT) and randomhexamerpriming (RH) fromRNA. Shown is detectionof snoRNAsequences
by qPCR using the indicated snoRNA-specific forward primers and the exogenous universal reverse primer and detection of pre-mRNA and mRNA using
forward and reverse primers designed within Rpl13a exon 2, which lies upstream of the snoRNAs in the transcript. Results are mean S.E. (error bars) for n
3. p 0.05, using Student’s t test (*).
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fected by brefeldin A, suggesting that release of these RNAs
did not require classical secretory pathways (Fig. 4, A and B).
Appearance of Rpl13a snoRNAs in the medium was also stim-
ulated by 2-hydroxypropyl--cyclodextrin and ionomycin,
agents known to induce EV secretion though mechanisms that
are distinct from LPS treatment (25, 26) and that do not lead to
ROS generation (Fig. 4, C andD). Together, these observations
suggested that release of Rpl13a snoRNAs into the medium
might occur through EV secretion.
To determine whether snoRNAs in the medium are associ-
ated with EVs, we concentrated EVs from macrophage-condi-
tioned medium following LPS treatment using either a com-
mercial precipitation reagent that enriches for exosomes or
differential centrifugation. Ultrastructural analysis of pellets
isolated with both methods revealed membrane-bound struc-
tures with diameters of 70–200 nm (Fig. 5A), whereas these
structures were absent from nonconditioned medium (not
shown). In these quick-freeze deep-etch electron micrographs,
either the true (outer)membrane surface or the smooth surface
that results from fracturing through the two leaflets of the
bilayer (p face) is visible at the perimeter of the vesicle. These
data indicate that bone marrow–derived macrophages treated
with LPS release EVs. Moreover, in EV-enriched fractions pre-
pared by either method, Rpl13a snoRNAs were detected at
baseline and increased following treatment of cells with LPS or
ionomycin, indicating that macrophages constitutively release
EV-associated snoRNAs but tightly regulate partitioning of
snoRNAs for EV-mediated export in response to these stimuli
(Fig. 5B). Recovery of EV-associated snoRNAs was more effi-
cient following precipitation than ultracentrifugation, consis-
tent with previous reports of higher yields from precipitation
(27). EV preparations were enriched for the integral membrane
proteins, flotillin andCD9, and relatively depleted for endoplas-
mic reticulum (calnexin) and nuclear (histone H3) markers
(Fig. 5C). The absence of correlation between magnitude of
stimulated EV-associated snoRNA secretion and EV-associ-
ated protein secretion between the two isolation methods
and the lack of increase in EV-associated proteins between
unstimulated and stimulated samples are observations that
suggest snoRNA-containing EVs released uponLPSor ionomy-
cin treatment represent a small fraction of the total secreted
EVs.
To distinguish between co-fractionation and true association
of Rpl13a snoRNAs with EVs, we separated EVs isolated by
ultracentrifugation frompotentially nonvesicular co-sediment-
ing components by floating the EVs into a continuous sucrose
gradient. Both Rpl13a snoRNAs and EV membrane protein
markers were enriched at a density between 1.14 and 1.20
g/cm2, the characteristic density for EVs (Fig. 6A). Rpl13a
snoRNAs in these EVs were resistant to RNase treatment but
degradedwhen treatedwith RNase in the presence of detergent
(Fig. 6B), suggesting that the snoRNAs are protected by amem-
brane. Together, our findings support amodel in whichmacro-
phages release EVs containing snoRNAs.
EV-associated Rpl13a snoRNAs are internalized by recipient
cells
Secreted RNAs can impact the biology of target cells by
engaging cell surface receptors or by uptake through endocyto-
sis or macropinocytosis. To determine whether RNA from
macrophage-derived EVs is incorporated into recipient cells,
EVs were enriched from the medium of donor cells that had
been metabolically labeled with ethynyl uridine and incubated
for 45 min with unlabeled recipient cells. Following washing to
remove surface-bound material, recipient cells were probed
with anAlexa Fluor 594–linked click reagent. RNA fromdonor
cell EVs was detected in the nucleus, where it co-localized with
fibrillarin (Fig. 7A). The dye-only control indicates that any
small amount of free dye that might remain after labeling and
cleanup does not cause detectable nucleolar staining. In an
alternate approach, RNAand lipids of isolated EVswere stained
with Syto RNAselect and 1,1-dioctadecyl-3,3,3,3-tetrameth-
ylindotricarbocyanine perchlorate (DiD), respectively, and
incubated with recipient cells. In the recipient cells, labeled
RNA was distributed throughout the cytoplasm and nucleus
and concentrated in nuclear structures suggestive of nucleoli
(arrowheads), a pattern that was distinct from background
autofluorescence in the dye-only control (Fig. 7B). DiDwas also
transferred to recipient cells and was distributed in cytosolic
punctae. Together, these findings indicate that both RNA and
lipid constituents of EVs are transferred.
Approaches in which RNA is followed by ametabolic label or
dye cannot formally distinguish between uptake of exogenous
EV components and transfer of free label or dye that has parti-
tioned into the EVs. To specifically assess whether secreted
snoRNAs are taken up into recipient cells, we isolated cells
from WT mice and from mice with germ line knockout of all
four Rpl13a snoRNAs (KO) (28). KOmice are viable and fertile
with no overt pathophysiological phenotype under standard
housing and feeding conditions. However, pancreatic islets
from these mice have decreased ROS tone, resistance to oxida-
tive stress stimuli, and enhanced insulin secretion and mito-
chondrial proton leak.
WT and KO macrophages were co-cultured in a transwell
apparatus that maintains the cells in separate compartments
separated by a membrane with 1-m pores. In this setting,
medium and associated EVs were freely shared between the
cells of different genotypes, but PCR analysis of DNA con-
firmed that cellular material was not transferred (Fig. 8A). In
situ hybridization to detect snoRNA U33 revealed scattered
nuclear puncta and larger areas of nuclear accumulation con-
sistent with nucleoli in singly cultured WT cells (Fig. 8, B and
C). ComparedwithKOmacrophages that had been co-cultured
with KOmacrophages, KOmacrophages co-cultured withWT
Figure 3. Macrophages secrete box C/D and box H/ACA snoRNAs in
response to LPS.Macrophages were treated with 50 ng/ml LPS for 1 h. A–D,
qRT-PCR of box C/D snoRNAs SNORD82 (A) and SNORD92 (B) and box H/ACA
snoRNAs SNORA16a (C) and SNORA73b (D) in the medium. Results are
mean  S.E. (error bars) relative to C. elegans miR39 spike-in for n  3. p 
0.05, using Student’s t test (*).
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macrophages demonstrated significantly increased nuclear
punctae, consistentwith transfer ofU33.Whereas the signal for
this single snoRNA species is small compared with the signal
for total labeled RNA (Fig. 7), the co-culture approach (Fig. 8)
provides further evidence of snoRNA transfer under more
physiological conditions.
LPS increases Rpl13a snoRNAs in the serum ofmurinemodel
and human volunteers
Because LPS triggers EV release of snoRNAs from cultured
macrophages, we asked whether this inflammatory stimulus
precipitated secretion of snoRNAs in vivo by treatingmice with
LPS. Compared with PBS-treated mice, animals that received
LPS demonstrated a rapid increase in EV-associated Rpl13a
snoRNAs in the serum over 4 h, concomitant with an increase
in hepatic inflammatory gene expression (Fig. 9, A and B). We
extended these findings by quantifying serum snoRNAs in
healthy human volunteers undergoing intrabronchial instilla-
tion of LPS for a study of lung inflammation (29). Although the
dose of LPS was small and delivered locally in the lungs, an
increase in C-reactive protein, white blood cell count, and per-
centage of polymorphonuclear leukocytes 6 h following the
procedure indicated the presence of systemic inflammation
(Fig. 9C). Compared with pretreatment conditions, levels of
U32a,U33, andU35a in serumEVswere significantly increased,
and levels of U34 trended up (Fig. 9D). Thus, in mice and in
humans, as we previously observed in cultured macrophages,
LPS induces secretion of snoRNAs, most likely in EVs.
Secreted snoRNAs direct new 2-O-methylation in vivo
To determine whether secreted snoRNAs can function in
distant tissues in vivo, we employed a parabiosismodel inwhich
WTmice expressing GFP in all tissues were surgically joined to
Rpl13a snoRNAKOmice (Fig. 10A). PCR analysis ofDNA from
tail blood of the parabionts revealed the presence of both the
WT and KO alleles in the circulation of each parabiont by 1
week following surgery (Fig. 10B), consistent with reports of
rapid development of shared circulation in this model (30). To
test for the function of the Rpl13a snoRNAs, we utilized a
qPCR-based method for detection of 2-O-methylation of
RNA, the modification that these snoRNAs direct on their
canonical rRNA targets (31, 32). In this assay, the covalent
modifications of the template cause reverse transcriptase to
stall at low deoxyribonucleotide concentrations, such that
larger amounts of qPCRproduct indicate lessmodification (Fig.
11A). This approach revealed the expected increases in ampli-
fication across Rpl13a snoRNA–directed 2-O-methylation
sites on the 18S and 28S rRNAs in KO compared with WT
macrophages (Fig. 11B).
We applied this method for analysis of Rpl13a snoRNA–
directed rRNA modifications to tissues harvested 3 weeks fol-
lowing surgery from KO and WT parabionts. Because new
rRNA transcription correlates with cell replication (33) and
2-O-methylation occurs on nascent rRNAs (34), we chose for
study the intestinal epithelium, where cells turn over every 2–3
days (35). Liver tissue served as a negative control, because
Figure 4. LPS stimulates nonclassical secretion of snoRNAs. A and B, macrophages were untreated (UT) or treatedwith 50 ng/ml LPS for 1 h in the absence
or presence of 10 g/ml BFA. A, qRT-PCR of snoRNAs U32a, U33, U34, and U35a in medium relative to C. elegans miR39 spike-in. B, LDH release as a mea-
sure of cell death. LDH-positive control and freeze-thaw lysis (MAX) are shownas controls.C, quantification of ROSbyDCF staining and flow cytometric analysis
following treatmentwithCDor IO.D, qRT-PCRof snoRNAs inmedium fromCD-or IO-treatedcells. Results aremeansS.E. (error bars) forn3. *,p0.05using
ANOVA with Dunnett’s multiple-comparison test.
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hepatocytes divide approximately once in 150 days in the adult
mouse (36), and therefore new rRNA synthesis and 2-O-meth-
ylation are expected to occur at much slower rates. Compared
with KO mice that had not undergone parabiosis, enterocytes
ofKOparabionts showed a significant decrease in amplification
(relative quantification; RQ), indicating an increase in modifi-
cation of all four Rpl13a snoRNA target sites (lower RQ) and
phenocopying the WT parabiont and WT animal control (Fig.
12A). By contrast, in liver tissue, we observed no significant
difference inmodification (RQ) at target sites for U32a andU33
between KO controls and KO parabionts, despite a clear differ-
ence between KO controls and either WT controls or WT
paraboints (Fig. 12B). Unexpectedly, there was no difference
betweenWT and KO controls in apparent methylation in liver
tissue at the U34 or U35a snoRNA target sites, raising the pos-
sibility that these target sites are unmodified in WT livers or
that other snoRNAs could be up-regulated specifically in the
KO livers to compensate for the loss of the Rpl13a snoRNAs.
Importantly, GFP expression remained undetectable in the KO
parabiont (Fig. 12, C and D), indicating the lack of transfer of
cellular material. Taken together, our data provide evidence
that Rpl13a snoRNAs travel through the circulation and are
taken up by distant tissues in which they function to modify
their established RNA targets.
Discussion
Herein, we demonstrate that cultured macrophages secrete
Rpl13a snoRNAs in response to the inflammatory stimulus
LPS, most likely as cargo inside of EVs. Furthermore, we show
that LPS stimulates secretion of these snoRNAs in both mouse
models and in human subjects. By leveraging a recently gener-
ated mouse model with selective loss of the Rpl13a snoRNAs,
we show that these extracellular noncoding RNAs are taken up
by cultured macrophages, in which they traffic to the nucleus.
In parabiosis experiments, we demonstrate that these snoRNAs
are not simply inert passengers in EVs, but are also capable of
functioning in distant tissues. Together, our findings provide a
new understanding of the biology of snoRNAs and the reper-
toire of EVs.
EVs secreted from macrophages and other cell types can
carry not only membrane and protein components from their
cells of origin, but also RNAs that can be detected by sensitive
PCR or RNA-Seq–based methods from concentrated prepara-
tions of EVs. Microarray and RNA-Seq analyses have provided
Figure 5. snoRNAs are associated with EV fraction ofmedium. A, electronmicrographs of EV-enriched pellets recovered by precipitation and by ultracen-
trifugation from medium conditioned by macrophages treated with 50 ng/ml LPS for 1 h. Scale bar, 100 nm. B, qRT-PCR analyses of material recovered by
enrichment of exosomes frommedium, reported relative to C. elegansmiR39 spike-in. C, immunoblot analysis of EV enriched fraction from 2 106 cells and
whole-cell lysate (5 104 cells). Results are mean S.E. (error bars) for n 3. *, p 0.05 using ANOVA with Dunnett’s multiple-comparison test.
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Figure 6. Rpl13a snoRNAs are contained within secreted EVs. A, qRT-PCR for snoRNAs (relative to C. elegans miR39 spike-in) and Western blotting of
fractions collected froma continuous sucrose gradient (0.25–2M) after floating EVs enrichedby differential centrifugation fromovernightmacrophage culture
(1.6 107 cells). B, qRT-PCR of snoRNAs from EV-enriched fraction treatedwith RNase, Triton X-100, and RNase inhibitor (Inh) as indicated. Results aremean
S.E. (error bars) for n 3. *, p 0.05 using ANOVA with Dunnett’s multiple-comparison test.
Figure 7. EV tRNA. A, WT cells cultured with EVs from ethynyl uridine–labeledWT cells (EU RNA), fixed and stained for labeled RNAwith Alexa Fluor 594 azide
and-fibrillarin (FIB) antibody.Nucleiwere counterstainedwith 4,6-diamidino-2-phenylindole (DAPI). Dye control usedEVs fromcells not labeledwith ethynyl
uridine. Scale bar, 20 m. B, representative images of WT cells cultured with DiD– and Syto RNAselect–labeled WT EVs and fixed and stained with 4,6-
diamidino-2-phenylindole. Scale bar, 20 m. Images are representative of three independent experiments.
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evidence that in addition to mRNAs, long noncoding RNAs,
and microRNAs, a range of snoRNA species are present in EVs
secreted from cultured cells and in EVs isolated from human
blood (17–19, 21, 37). Our work extends these observations by
demonstrating that macrophage secretion of EV-associated
Rpl13a snoRNAs is stimulated by LPS, which is also known to
regulate secretion of microRNAs from macrophages (15). Fur-
thermore, we show that the Rpl13a snoRNAs are also secreted
in response to this inflammatory stimulus in mice and in
humans. For our in vivo analyses, we enriched for circulating
EVs by precipitation from serum samples. Whereas it is possi-
ble that serum EVs containing Rpl13a snoRNAs originate
from macrophages, these snoRNAs are widely expressed, and
snoRNA-containing EVs probably originate from additional
cell types in vivo.
Secretion of snoRNAs in vivo raises the possibility that these
RNAs traffic in a paracrine or endocrine fashion between cells
to impact the biology of recipient cells and to regulate organis-
mal physiology, as has been demonstrated for microRNAs (16).
In vitro, we used RNA labeling to show that concentrated EVs
from donor cells are taken up by recipient cells. We also lever-
aged primary macrophages from mice with loss of function of
the Rpl13a snoRNAs and from WT mice to demonstrate that
EV-associated snoRNAs are taken up by recipient cells and traf-
fic to the nucleus. Although we detected the presence of trans-
ferred EV RNA and transferred U33 snoRNA, we were unable
to consistently detect new 2-O-methylation in cultured recip-
ient cells treated with concentrated EVs or in co-cultured
macrophages. We hypothesize that this is because snoRNAs
direct 2-O-methyl modifications of newly transcribed pre-
rRNAs in the nucleolus, but not mature rRNAs (34). Tran-
scription of new rRNA is linked to progression through the
cell cycle, which is extremely slow in these nonreplicating
primary macrophages (33).
By contrast, in the parabiosis model usingWT and KOmice,
we find that Rpl13a snoRNAs are transferred through the
bloodstreamand can function in distant tissues, in a setting that
does not involve concentration of large quantities of biological
fluids. Two features of thismodel probably facilitated detection
of functional snoRNA transfer. First, although the mice were
not treated with LPS, sterile inflammation secondary to the
surgical procedure may have contributed to EV secretion. Sec-
ond, our data indicate that shared circulation is established
early. Because synthesis of new rRNAs is low in post-mitotic
cells and tissues, chronic exposure to snoRNA-containing EVs
over several weeks may have enabled detection of snoRNA
Figure 8. EVs transfer snoRNAs. A, representative agarose gel of genotyp-
ing PCR on DNA recovered from cells in the lower chamber of a transwell
culture plate.WT, WT cells in both upper and lower chambers. TW, WT cells in
the upper chamber and KO cells in the lower chamber. KO, KO cells in both
upper and lower chambers. B, in situ Alexa Fluor 546 labeling for U33 in KO
cells (lower chamber) that were co-cultured in a transwell apparatus withWT
cells or with KO cells (upper chamber). WT cells cultured alone are shown as
controls. Representative confocal micrographs are shown. C, quantification
of 8–9 random fields for each of three independent experiments, with an
average of 281 cells/condition. Scale bars, 20 m. Results are mean  S.E.
(error bars). *, p 0.05 using Student’s t test.
Figure 9. LPS stimulates snoRNA secretion in vivo. A and B, mice were
treated with 10 mg/kg LPS (n 18) or saline as control (PBS, n 12). At 4 h
after treatment, TNF expression (relative to Rplp0) in liver tissue (A) and
Rpl13a snoRNA abundance (relative to spike-in) in serum EVs (B) were quan-
tified by qRT-PCR. C and D, blood was analyzed from human subjects at time
0 (pre) and 6 h following (post) endobronchial installation of 4 ng/kg LPS.
Blood markers of inflammation, C-reactive protein (CRP), white blood cell
count (WBC), and percentage of polymorphonuclear leukocytes (PMN) were
quantified (C). Abundance of Rpl13a snoRNA levels in serum EVs (relative to
spike-in) was quantified by qRT-PCR (D). n 6 subjects. Results are mean
S.E. (error bars); *, p 0.05.
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function in rapidly replicating enterocytes, whichmust synthe-
size and 2-O-methylate new rRNAs. Although our studies
demonstrate acquisition of new snoRNA-directed modifica-
tions, we were unable to consistently detect Rpl13a snoRNAs
by qRT-PCR in KO parabiont tissues (not shown). This sug-
gests that snoRNAs are short-lived in recipient tissues relative
to the RNA marks they generate and/or that a relatively small
number of transferred snoRNA molecules catalyze a substan-
tially larger number of methylation events.
Macrophages play key roles in the response to infection or
tissue damage through their activation, polarization, and com-
municationwith the extracellular environment. Although it has
long been appreciated that the secreted protein cytokines are
key mediators of communication between macrophages and
distant tissues, evidence is emerging that macrophage-secreted
EVs play important roles in pathophysiological responses to
inflammation. In the setting of infections with the intracellular
pathogens Mycobacteria and Listeria, macrophages secrete
EVs that promote inflammatory signaling, cell migration, and
protective T cell–mediated immune responses in vivo (38–40).
Macrophage-derived EVs have also been shown to play a criti-
cal role in the regenerative response of intestinal stem cells
following radiation injury (41). In some instances, these func-
tions have been associated with EV transfer of protein antigens
(39) or signaling molecules (41). Thus, macrophage EVs have
been implicated to serve as immunoregulators. Our data
show that macrophage-derived EVs contain snoRNAs that are
known to target rRNAs for 2-O-methylation, suggesting that
the functional repertoire of macrophage EVs may include
broader processes for cellular homeostasis, such as protein
expression or cellular growth.
Future studies will be required to elucidate the spectrum of
signals that regulate snoRNA secretion, the mechanisms for
selection of snoRNAs as EV cargo, and whether specific sub-
classes of EVs carry snoRNAs. The rapidity of release of EVs
containing snoRNAs following treatment with ionomycin or
LPS suggests that these stimuli promote release of preformed
snoRNA-containing EVs. Although secreted snoRNAs that
direct rRNAmodifications in recipient cells may mediate cell–
cell communication, the physiological role of snoRNA secre-
tion remains to be determined. The finding of augmentedmito-
chondrial proton leak in tissues of the Rpl13a-snoRNA KO
mouse suggests that a noncanonical function of the snoRNAs is
to promote tightly coupled respiration (28). Based on this, we
hypothesize that EV-mediated snoRNA transfer could enhance
metabolic efficiency in recipient cells, thereby improving cell
survival in the face of stress and/or infection. Characterization
of the physiological contexts that precipitate secretion of
snoRNAs could reveal opportunities in which the Rpl13a
snoRNAs or other snoRNAs might serve as biomarkers for
detection or management of disease. Given that snoRNAs
are sensitive to antisense knockdown, these noncoding
RNAs have the potential to serve as targets for new thera-
peutic approaches.
Figure 10. Parabiosis model establishes shared circulation. A, parabiosis
surgery was performed to join the circulations of WT (/) and KO (/)
mice. The WT mice express GFP (*) in all tissues. Following parabiosis, the
presence of GFP in blood stream of both parabionts indicates shared circula-
tion. Analyses for snoRNA transfer to parenchymal tissues of KO parabiont
were performed 3 weeks after surgery following perfusion to remove blood.
B, representative agarose gel of genotyping PCR on DNA recovered from
blood collected before and 1 week after surgery from three parabiosis pairs
with WT and KO controls.
Figure 11. Detection of Rpl13a snoRNA function. A, schematic for primer
extension qRT-PCR for detection of 2-O-methylation (2-O-ME). Under stan-
dard dNTP concentrations, cDNA synthesis proceeds regardless of template
RNA methylation (red cross). At low, but not high, dNTP concentrations,
reverse transcriptase stalls at themethylation site and falls off of the template.
Concentration of dNTP has no effect on unmethylated RNA template. Thus,
the ratio of qRT-PCR efficiency under low/high dNTP (RQ) inversely correlates
with methylation at the site of interest. B, primer extension qRT-PCR for
known rRNA target sites forRpl13a snoRNAs inWTandKOmacrophages (18S,
G1328 forU32a; 18S, U1326 forU33; 28S, U2590 forU34; 28S, C4188 forU35a).
Low RQ indicates more 2-O-methylation. High RQ indicates less/no 2-O-
methylation. Results are mean  S.E. (error bars); n  3; *, p  0.05 using
Student’s t test.
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LPS, BFA, IO, CD, and staurosporine were from Sigma-
Aldrich. -Fibrillarin (ab4566), -nucleophosmin (ab15440),
-flotillin 1 (ab50673), and -calnexin (ab22595) antibodies
were fromAbcam (Cambridge,MA).-HistoneH3 (catalog no.
9717) antibody was from Cell Signaling (Danvers, MA). -CD9
(catalog no. 564236) was from BD Biosciences.
Mice
FVB and FVB.Cg-Tg(CAG-EGFP)B5Nagy/J were obtained
from the Jackson Laboratory (Bar Harbor, ME), and Rpl13a-
snoless (KO) mice (28) were maintained in facilities under spe-
cific pathogen-free conditions at Washington University (St.
Louis, MO). Bone marrow was isolated as described below.
Blood samples were obtained from male and female mice 4 h
following intraperitoneal injection of 10 mg/kg LPS. All exper-
imental procedures were approved by theWashington Univer-
sity Animal Studies Committee and were conducted in accord-
ance with the United States Department of Agriculture Animal
Welfare Act and the Public Health Service Policy for the
Humane Care and Use of Laboratory Animals.
Bonemarrow–derivedmacrophages
Bonemarrowwas harvested from the tibia and femur ofmale
and femalemice. Cells were seeded and differentiated for 6 days
in 10% CMG14.12 conditioned medium (42). CMG14.12 cells
were a gift from the laboratory of Deborah Veis (Washington
University). Cells were treated with 50 ng/ml LPS for the indi-
cated times, 10 g/ml BFA for 90 min, 0.5 M IO for 15 min, or
2% CD for 60 min. Cell death was measured using the Cyto-
tox96 nonradioactive cytotoxicity assay (Promega, Madison,
WI). LDH controls contained LDH from the kit (1:5,000 dilu-
tion of 1,600 units/ml solution), and the maximum signal was
determined by measuring LDH activity in the medium of cells
cultured under identical conditions and lysed by quickly freez-
ing and thawing the plate. Apoptosis was quantified by a
caspase 3/7 Glo assay (Promega, Madison, WI). ROS was
Figure 12. Secreted snoRNAsdirect new2-O-methylation in vivo. Enterocytes (A andC) and liver tissue (B andD) were isolated fromKOandWTparabionts
(PB;n 10 eachgenotype) and fromunpaired KO (n 5) andWT (n 3) controls.A and B, primer extensionqRT-PCR for detection of 2-O-methylation of rRNA
targets for Rpl13a snoRNAs (18S, G1328 for U32a; 18S, U1326 for U33; 28S, U2590 for U34; 28S, C4188 for U35a). C andD, qRT-PCR analysis for detection of GFP
expression. Results are mean S.E. (error bars); *, p 0.05 by ANOVA with Dunnett’s multiple-comparison test.
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detected by measuring fluorescence on a TECAN Infinite 200
PRO multimode reader (Tecan, Männedorf, Switzerland) after
cells were loaded with 10 M DCF (Thermo Fisher Scientific,
Carlsbad, CA). Sequential detergent extraction was performed
as described previously to generate nuclear and cytosolic frac-
tions (10).
EV enrichment, labeling, and transfer
EVswere isolated from cell culturemedium using Total Exo-
some isolation reagent (Thermo Fisher Scientific) (43), or EVs
were isolated by differential centrifugation (44). Serum EVs
were isolated with Exoquick (System Biosciences, Mountain
View, CA) according to the manufacturer’s instructions (38).
Culture medium used for EV labeling/transfer and floatation/
RNase treatment experiments was depleted of EVs before use
by centrifugation at 120,000  g for 90 min. Conditioned
medium was cleared by centrifugation for 10 min at 1,000 g,
followed by centrifugation for 20 min at 2,000  g, and then
concentrated using an Amicon Ultra-15 centrifugal filter unit
with Ultracel-10 membrane (3,500 g, 20 min; Millipore, Bil-
lerica, MA). EVs were floated into a continuous sucrose gradi-
ent as described previously (44). A small sample was taken from
each fraction, and density was measured at room temperature
using an Atago (Bellevue, WA) three-range sugar hand refrac-
tometer (0–90%).
For EV transfer experiments, EVs were labeled using Syto
RNA select and DiD (Thermo Fisher Scientific) according to
the manufacturer’s instructions, and unincorporated dye was
removed either by washing in Amicon filters or with Exosome
spin columns (Thermo Fisher Scientific) with similar results.
Dye controls were treated in an identical manner. Ethynyl
uridine–labeled EVs were collected from cells cultured over-
night with 0.5mM ethynyl uridine (45). Following incubation of
recipient cellswith EVs for 45min, cellswerewashed twicewith
3% BSA (Sigma-Aldrich) in PBS, fixed with 3.7% paraformalde-
hyde, (Electron Microscopy Science, Hatfield, PA), and per-
meabilized with 0.5% Triton X-100 (Sigma-Aldrich). Ethynyl
uridine was detected using the Click iT RNA imaging kit (Alexa
Fluor 594, Thermo Fisher Scientific). For transwell transfer, 106
KO and WT bone marrow cells were grown for 7 days or until
confluent in conditioned medium in chambers separated by
Thincert 1-m pore membranes (Greiner Bio-one) in 6-well
plates and stained using the Quantigene ViewRNA Cell Plus
assay with Alexa Fluor 546 detection, modified to include an
additional fixation with 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide hydrochloride and protease treatment with re-
agents from the miRNA assay kit. Control wells were assayed
for transfer of genomic material using genotyping primers for
WT and KO Rpl13a loci (28).
qRT-PCR
RNA was purified using TRIzol. Relative quantification of
RNA abundance was calculated using the 		Ctmethod on an
ABI 7500 fast real-time PCR system. Primer sequences for
COX2were TGAGCAACTATTCCAAACCAGC (forward)
and GCA CGT AGT CTT CGA TCA CTA TC (reverse); for
TNF, theywere CATCTTCTCAAAATTCGAGTGACAA
(forward) and TGG GAG TAG ACA AGG TAC AAC CC
(reverse); and for Rplp0, they were ATC CCT GAC GCA CCG
CCG TGA (forward) and TGC ATC TGC TTG GAG CCC
ACG TT (reverse). The method for qRT-PCR for Rpl13a
snoRNAs used target-specific stem loop RT primers, a target-
specific forward PCR primer, and a universal reverse PCR
primer (46). This method can detect as few as 103 copies of
target RNAs, is able to distinguish between small RNA species
that differ by only 1 nucleotide, is not affected by genomic
contamination, distinguishes mature snoRNAs and miRNAs
from their precursor small RNA species, and has been validated
against RNA-Seq for snoRNAs (10, 47, 48). mRNA quantifica-
tion was calculated using Rplp0 as an endogenous control. For
quantification of EV RNA, Caenorhabditis elegansmiR39 (500
fmol) or luciferasemRNA (0.3 fmol; Promega) was added to EV
samples before RNA isolation and used as a reference control.
Amplification of reference genes varied by1 cycle across sam-
ples. A plate of 2 106 cells was used for cellular fractionation
by sequential detergent extraction, and medium was pooled
from three plates.
Microscopy
Freeze fracture/deep etch EM was performed according to
published protocols with minor modifications (49). A 4-l
droplet of samplewas placed on top of a 4 4-mmacid-cleaned
and air-dried coverslip and then topped with a 3-mm round
sapphire disc. Samples were immediately frozen by abrupt
application of the sample against a liquid helium–cooled cop-
per block with a Cryopress freezing machine. Frozen samples
were transferred to a liquid nitrogen–cooled Balzers 400 vac-
uum evaporator, fractured at 100 °C by removal of the sap-
phire disc with the instrument’s nitrogen cooled knife. Samples
were etched for 2 min at 100 °C and rotary replicated with

2-nmplatinumdeposited from a 20º angle above the horizon-
tal, followed by an immediate
4-nm stabilization film of pure
carbon deposited from an 85º angle. Replicas were floated onto
a dish of concentrated hydrofluoric acid for coverslip removal
and then transferred through several rinses of distilled H2O
with a loopful of Photoflo, picked up on Formvar-coated grids,
and photographed on a JEOL 1400 microscope with attached
AMT digital camera. Confocal images were taken on a Zeiss
LSM 880 Airyscan confocal microscope with a 0.8-m pinhole
through a focal plane in the center of the nuclei and processed
using Zen software (Zeiss, Oberkochen, Germany).
RNase protection
EVs enriched by ultracentrifugation were suspended in 250
l of PBS and treated with 0.3% Triton X-100, 1 unit of RNase
A, 40 units of RNase T1 (Ambion RNase mixture, Thermo
Fisher Scientific), and 100 units of SUPERase-In RNase inhibi-
tor (Thermo Fisher Scientific) for 30 min at 20 ºC, and then
RNase inhibitor was added to all samples. RNA was isolated
using TRIzol LS.
Human subjects
Blood samples were collected from human volunteers for a
study of lung inflammation before and 6 h following endobron-
chial instillation of 4 ng/kg LPS (29). This study was approved
by the Washington University Human Research Protection
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Office and complieswith theDeclaration ofHelsinki principles.
Informed consent was obtained from all subjects.
Parabiosis
The Washington University Mouse Cardiovascular Pheno-
typing Core performed parabiosis surgery using female WT
mice expressing GFP and Rpl13a snoRNA KO mice as
described (30). Tail vein blood was sampled serially from the
parabionts for PCR analysis of DNA to detect the WT and KO
Rpl13a loci with primers GAC AGG TTG CTG CTC AGG
AAG TAA ATGG (forward) and CCA GAC CTG CTT TCA
GACTTTAGCCTG (reverse). Threeweeks following surgery,
parabionts were perfused with PBS to clear blood from tissues
and euthanized. Enterocytes and liver were recovered and
flash-frozen in liquid nitrogen. For PCR analysis, tissues were
homogenized in TRIzol.
Primer extension qRT-PCR
Primer extension PCR to detect rRNA methylation was
adapted from Dong et al. (31). For each target, 20 ng of total
RNA was used in cDNA synthesis using the Super Script III kit
(Thermo Fisher Scientific) with 0.3l of SSIII enzyme per reac-
tion and dNTP at either the normal stock concentration (50
M) or diluted 1:1,000 (50 nM). The following primers were
used for each RT reaction: m18S RT (U32a, G1328), CAACTA
AGA ACGGCC ATG CA; m18S RT (U33, U1326), AGA ACG
GCC ATG CAC C; m28S RT (U34, U2590), GAC TTC CCT
TAC CTA C; and m28S RT (U35a, C4188), AAC CTG TCT
CAC GAC G. qPCR was done on a 7500 fast real-time PCR
system with SYBR Green real-time PCR master mix (Thermo
Fisher Scientific). PCR primers used were as follows: m18S F2
(U32a/33), GGC CTG CGG CTT AAT TTG AC; m18S R2
(U32/33), ATGCACCACCACCCACG;m28S F1 (U34), TCT
CGC TGG CCC TTG AAA AT; m28S R1 (U34), ACC TAC
ATTGTTCCAACATGCC;m28S F1 (U35a), CTTCGATGT
CGG CTC TTC CT; m28S R1 (U35a), TCA CGA CGG TCT
AAA CCC AG. RT efficiency was calculated by normalizing the
Ct value for the low dNTP concentration to the high as an endog-
enous control (RQ). For each modification site within a specific
tissue, values are reported relative to themeanWT value.
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